Xin Lang Cai Jing·2026-03-17 02:45Group 1 - The core viewpoint of the article highlights a significant rise in the innovative drug sector, with Rongchang Biopharmaceuticals increasing nearly 7% to reach a historical high, alongside other companies such as Sanofi, Yuandong Biopharmaceuticals, Yuekang Pharmaceuticals, Junshi Biosciences, Bibete, and Yifang Biopharmaceuticals also experiencing gains [1] Group 2 - The Ministry of Industry and Information Technology held a cadre meeting emphasizing the cultivation and expansion of emerging industries and future industries, particularly focusing on the biopharmaceutical sector as a new pillar industry [1] - The meeting also discussed the establishment of mechanisms for increasing investment in future industries and sharing risks [1]